FDA DEVICE FACTS
Rapid Vessel Occlusion (Rapid VO)
iSchemaview
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Rapid VO is a radiological computer aided triage and notification software indicated for use in the analysis of CTA adult head images. The device is intended to assist hospital networks and trained clinicians in workflow triage by flagging and communication of suspected positive Large iSchemaView - Traditional 510(k) Rapid Vessel Occlusion (Rapid VO) Vessel Occlusion findings in head CTA images including the ICA, MCA (M1-M2), and Basilar vascular segments.
Rapid VO uses an AI software algorithm to analyze images and highlight cases with suspected occlusion on a server or standalone desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected occlusion findings. Notifications include compressed preview images. These are meant for informational purposes only and are not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device. The results of Rapid VO are intended to be used in conjunction with other patient information and based on professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care. Rapid VO is for use on adults. Caution(s)/Warnings(s)/Limitation(s)/Exclusion(s)/Contraindications(s):
• Input data image series containing excessive patient motion or metal implants.
• Series containing inadequate contrast agent
• Series that are non-axial or non-axial oblique
• Series with missing slices or improperly ordered slices
• CTA datasets with:
• in-plane X and Y FOV < 160mm or > 400mm.
• Z FOV (cranio-caudal transverse anatomical coverage) < 90 mm or > 600 mm
• y-plane pixel spacing (X & Y resolution) < 0.15 mm or > 0.8 mm.
• Z slice spacing of < 0.2 mm or > 1.5 mm.
• lice thickness > 1.5 mm.
• data acquired at x-ray tube voltage < 70kVp or > 150kVp.
• data not representing human head or head/neck anatomical regions Technological Characteristics and Substantial Equivalence: Rapid VO does not raise new questions of safety or effectiveness compared to the previously cleared Rapid CTA 360 Software (K251151). There are minor differences in intended use and technical characteristics with the predicate device; however, with the minor changes the clinical use for Rapid VO device is the same with no additional risks. Thus, the Rapid VO software device is substantially equivalent. The following table summarizes and compares data on the predicate device (K251151) to the Rapid VO software device that is the subject of this Traditional 510(k) submission. iSchemaView - Traditional 510(k) Rapid Vessel Occlusion (Rapid VO) Parameter Rapid CTA 360 (K251151)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。